Cabergoline-Induced Hypoprolactinemia May Attenuate Cardiometabolic Effects of Atorvastatin: A Pilot Study

INTRODUCTION: Hypoprolactinemia, which is usually a consequence of treatment with inadequate high doses of dopaminergic agents, is a poorly understood clinical condition. The aim of the current study was to investigate whether the cardiometabolic effects of statin therapy differ between patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Krysiak, Robert, Kowalcze, Karolina, Okopień, Bogusław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Cardiovascular Biomarkers: Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808652/
https://www.ncbi.nlm.nih.gov/pubmed/36195057
http://dx.doi.org/10.1159/000527333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808652/
https://www.ncbi.nlm.nih.gov/pubmed/36195057
http://dx.doi.org/10.1159/000527333

Ejemplares similares